State switches stance on hepatitis C drugs, expands access, but not all Medicaid patients qualify 

Diabetes Drugs May Slow Disease Activity in Multiple Sclerosis
September 14, 2016
Why the misdiagnosis of multiple sclerosis (MS) is common
September 15, 2016
Show all

State switches stance on hepatitis C drugs, expands access, but not all Medicaid patients qualify 

The state of Illinois has policy change that will allow more patients to get treatment for hepatitis C.

The state of Illinois has backed off a 2-year-old policy that allowed only its sickest residents with hepatitis C who rely on the traditional Medicaid program to get disease-curing drugs.

The policy change, announced Friday evening, means Illinois residents on Medicaid with stage 3 liver scarring — not just the sickest patients with stage 4 liver scarring — will be able to access the drugs. If left untreated, hepatitis C can lead to liver failure, cancer and even death.

At least 12,000 Illinoisans covered by Medicaid had been diagnosed with hepatitis C as of last year, according to the state.

The disease is transmitted primarily through blood contact, meaning drug users who share needles are at risk, as are those who get tattoos in nonsterile conditions and anyone who got a blood transfusion before 1992, when screening of the blood supply began.

Read Full Article: State switches stance on hepatitis C drugs, expands access, but not all Medicaid patients qualify – Chicago Tribune

Read Full Article: State switches stance on hepatitis C drugs, expands access, but not all Medicaid patients qualify – Chicago Tribune

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.